10 20 30 40 50 60 70 80 1LRB - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 15-MAY-02 1LRB
TITLE CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 10A
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHODIESTERASE 10A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC COMPND 6 PHOSPHODIESTERASE 10A; COMPND 7 EC: 3.1.4.17
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN
KEYWDS PDE PHOSPHODIESTERASE
EXPDTA THEORETICAL MODEL
AUTHOR S.SUNITATAJNE,S.RAMADEVI,R.JOHN
REVDAT 2 20-NOV-02 1LRB 1 REMARK REVDAT 1 05-JUN-02 1LRB 0
JRNL AUTH S.SUNITATAJNE,S.RAMADEVI,R.JOHN JRNL TITL CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 10A JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CHARMM REMARK 3 AUTHORS : BROOKS,BRUCCOLERI,OLAFSON,STATES,SWAMINATHAN, REMARK 3 KARPLUS REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1LRB COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-MAY-2002. REMARK 100 THE RCSB ID CODE IS RCSB016212.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THIS MODEL IS BASED UPON THE COORDINATES OF PDB ENTRY REMARK 220 1F0J.PDB:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ILE A 234 N ILE A 234 CA 0.111 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 79 THR A 80 -139.63 REMARK 500 ASN A 145 LEU A 146 -145.50
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LRC RELATED DB: PDB REMARK 900 1LRC CONTAINS CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3A
DBREF 1LRB A 1 257 UNP Q9Y233 CN10_HUMAN 501 757
SEQRES 1 A 257 PHE ILE MET SER VAL LYS LYS ASN TYR ARG ARG VAL PRO SEQRES 2 A 257 TYR HIS ASN TRP LYS HIS ALA VAL THR VAL ALA HIS CYS SEQRES 3 A 257 MET TYR ALA ILE LEU GLN ASN ASN HIS THR LEU PHE THR SEQRES 4 A 257 ASP LEU GLU ARG LYS GLY LEU LEU ILE ALA CYS LEU CYS SEQRES 5 A 257 HIS ASP LEU ASP HIS ARG GLY PHE SER ASN SER TYR LEU SEQRES 6 A 257 GLN LYS PHE ASP HIS PRO LEU ALA ALA LEU TYR SER THR SEQRES 7 A 257 SER THR MET GLU GLN HIS HIS PHE SER GLN THR VAL SER SEQRES 8 A 257 ILE LEU GLN LEU GLU GLY HIS ASN ILE PHE SER THR LEU SEQRES 9 A 257 SER SER SER GLU TYR GLU GLN VAL LEU GLU ILE ILE ARG SEQRES 10 A 257 LYS ALA ILE ILE ALA THR ASP LEU ALA LEU TYR PHE GLY SEQRES 11 A 257 ASN ARG LYS GLN LEU GLU GLU MET TYR GLN THR GLY SER SEQRES 12 A 257 LEU ASN LEU ASN ASN GLN SER HIS ARG ASP ARG VAL ILE SEQRES 13 A 257 GLY LEU MET MET THR ALA CYS ASP LEU CYS SER VAL THR SEQRES 14 A 257 LYS LEU TRP PRO VAL THR LYS LEU THR ALA ASN ASP ILE SEQRES 15 A 257 TYR ALA GLU PHE TRP ALA GLU GLY ASP GLU MET LYS LYS SEQRES 16 A 257 LEU GLY ILE GLN PRO ILE PRO MET MET ASP ARG ASP LYS SEQRES 17 A 257 LYS ASP GLU VAL PRO GLN GLY GLN LEU GLY PHE TYR ASN SEQRES 18 A 257 ALA VAL ALA ILE PRO CYS TYR THR THR LEU THR GLN ILE SEQRES 19 A 257 LEU PRO PRO THR GLU PRO LEU LEU LYS ALA CYS ARG ASP SEQRES 20 A 257 ASN LEU SER GLN TRP GLU LYS VAL ILE ARG
HELIX 1 1 PHE A 1 ASN A 8 1 8 HELIX 2 2 ASN A 16 LEU A 31 1 16 HELIX 3 3 THR A 39 HIS A 53 1 15 HELIX 4 4 SER A 61 PHE A 68 1 8 HELIX 5 5 HIS A 70 TYR A 76 1 7 HELIX 6 6 THR A 80 ILE A 92 1 13 HELIX 7 7 LEU A 93 LEU A 95 5 3 HELIX 8 8 SER A 105 ALA A 122 1 18 HELIX 9 9 THR A 123 ALA A 126 5 4 HELIX 10 10 LEU A 127 THR A 141 1 15 HELIX 11 11 ASN A 148 LEU A 165 1 18 HELIX 12 12 CYS A 166 LYS A 170 5 5 HELIX 13 13 LEU A 171 LEU A 196 1 26 HELIX 14 14 GLU A 211 VAL A 223 1 13 HELIX 15 15 VAL A 223 LEU A 235 1 13 HELIX 16 16 GLU A 239 ARG A 257 1 19
CISPEP 1 ARG A 11 VAL A 12 0 24.61 CISPEP 2 ASP A 210 GLU A 211 0 1.99 CISPEP 3 PRO A 236 PRO A 237 0 -0.64
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000